Guillain-Barré Syndrome Warning Added to Shingrix Vaccine in Australia
In February 2024, Australia’s Therapeutic Goods Administration (TGA), the country’s national regulatory authority for drugs and, initiated an investigation into a potential association between GSK plc’s Shingrix shingles vaccine, Guillain-Barré syndrome (GBS), which causes inflammation and damage to the nerves, that may include paralysis.1 The investigation was prompted by two reports of GBS following Shingrix […]
FDA Lab Uncovers Excess DNA Contamination in COVID-19 Vaccines
An explosive new study conducted within the U.S. Food and Drug Administration’s (FDA) own laboratory has revealed excessively high levels of DNA contamination in Pfizer’s mRNA COVID-19 vaccine. Tests conducted at the FDA’s White Oak Campus in Maryland found that residual DNA levels exceeded regulatory safety limits by 6 to 470 times. The study was undertaken […]
Triathlete Who Suffered Torn Coronary Artery Days After COVID Shots Undergoes More Surgery
In mid-2021, triathlete and fitness instructor Ingi Doyle of Queensland, Australia received two doses of the Pfizer/BioNTech Comirnaty mRNA (messenger ribonucleic acid) COVID-19 biologic. The first shot on June 12, 2021 left her with a sore arm. After the second shot on July 4, she developed a severe adverse reaction that resulted in an aortic […]
Guillain-Barré Syndrome Linked to COVID-19 Shots
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]